SBMFF (Sino Biopharmaceutical) FFO


SBMFF Sino Biopharmaceutical Ltd SBMFF
63 GF Score
Price $0.60
GF Value $0.66
Valuation Fairly Valued
! 4 Warning Signs
View Full Analysis

What is Sino Biopharmaceutical FFO?

FFO (Funds from operations) only applies to REITs.

SBMFF
63GF Score
Sino Biopharmaceutical Ltd SBMFF
FFO is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is Sino Biopharmaceutical (SBMFF) Overvalued in 2026?

Based on GuruFocus' analysis, Sino Biopharmaceutical stock appears to be undervalued. The current stock price of $0.60 is trading 8.8% below its estimated GF Value™ of $0.66. GuruFocus considers Sino Biopharmaceutical to be Fairly Valued.

Key valuation signals for SBMFF:

  • FFO:
  • GF Value™: $0.66 vs. price of $0.60 (8.8% below fair value)
  • GF Score™: 63/100 with 4 warning signs

No single metric tells the full story. See the SBMFF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Sino Biopharmaceutical Business Description

Address 1 Harbour Road, Unit 09, 41st Floor, Office Tower, Room 4109, Convention Plaza, Wanchai, Hong Kong, HKG
Sino Biopharmaceutical Ltd is an investment holding company. The company and its subsidiaries are principally engaged in the research and development, production and sale of a series of pharmaceutical products. Its business covering the entire industrial chain of R&D, production and commercialization of drugs, biological products and high-end generic drugs. The company's therapeutic areas include: oncology, liver disease, respiratory, and surgery/pain relief. The company's revenue was generated from the sale of pharmaceutical products in the Chinese mainland.
63GF Score

Get the complete analysis for SBMFF

FFO is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$0.60
Price
$0.66
GF Value